MedTrace Logo

Efficacy of Different Biological Treatments in Patients With Inflammatory Bowel Disease After One Year of Treatment in Upper Egypt

NCT07495644 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2026-03-27

No results posted yet for this study

Summary

To study the efficacy of different biological treatment on patient with inflammatory bowel disease after one year of treatment in upper egypt

Conditions

  • Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)

Interventions

BIOLOGICAL

adalimumab, infliximab, ustekinumab, golimumab, and vedolizumab

Efficacy of different biological treatment on patient with inflammatory bowel disease

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mohamed Abaas Sabah, Professor · Assiut University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2027-03-31
Completion
2027-06-30
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07495644 on ClinicalTrials.gov